A 38-year-old woman with a family history of early macular dystrophy presents with mild metamorphopsia and paracentral scotomas. Visual acuity is 6/9 OU. Fundus examination reveals numerous, discrete, round, yellow-white drusen-like deposits arranged in a radial honeycomb pattern at the macula and extending around the optic disc. OCT shows sub-RPE hyperreflective deposits with overlying RPE and outer retinal preservation. Genetic testing confirms an autosomal dominant R345W mutation in the EFEMP1 gene encoding fibulin-3. The structure marked **A** in the diagram represents the confluent honeycomb drusen pattern characteristic of this condition. Which of the following best describes the biochemical nature and clinical significance of these deposits?
A. Choroidal neovascularization with secondary drusen formation, requiring immediate anti-VEGF therapy to prevent rapid central vision loss
B. Basal laminar deposits composed of basement membrane material that respond well to AREDS vitamin supplementation and typically stabilize with age
C. Lipofuscin-rich RPE cells undergo apoptosis, leading to geographic atrophy and irreversible vision loss within 5 years of symptom onset
D. Extracellular matrix protein (fibulin-3) misfolds and accumulates sub-RPE, causing early-onset macular dystrophy in younger patients (20s–40s) with autosomal dominant inheritance
Explanation
Why option 1 is correct
The structure marked A (confluent honeycomb drusen) in Doyne Honeycomb Retinal Dystrophy (DHRD) represents pathognomonic sub-RPE deposits composed of misfolded and accumulated fibulin-3 protein, an extracellular matrix component encoded by the EFEMP1 gene. The R345W mutation causes protein misfolding and accumulation, resulting in the characteristic radial honeycomb pattern visible on fundus examination and hyperreflective deposits on OCT. This is an autosomal dominant condition that presents in younger patients (20s–40s), distinguishing it from age-related macular degeneration which typically presents in older individuals. The biochemistry—extracellular matrix protein accumulation—is the defining pathophysiologic mechanism of DHRD (Marmorstein AD et al. EFEMP1 Doyne Review).
Why each distractor is wrong
Option 2: Lipofuscin accumulation and RPE apoptosis are features of some retinal dystrophies but not the primary mechanism of DHRD. Additionally, DHRD does not invariably progress to geographic atrophy within 5 years; the natural history spans decades with variable progression.
Option 3: Basal laminar deposits (cuticular drusen) are a distinct entity seen in pattern dystrophies and age-related macular degeneration, not DHRD. AREDS supplementation is not validated in DHRD, and the deposits in DHRD are sub-RPE extracellular matrix accumulation, not basement membrane material.
Option 4: While choroidal neovascularization can occur as a late complication in a minority of DHRD patients, it is not the primary pathophysiology of the honeycomb drusen marked A. The drusen themselves are not secondary to CNV but are the primary pathologic finding.
High-YieldNEET PG
DHRD = EFEMP1 mutation → fibulin-3 misfolding → sub-RPE extracellular matrix accumulation → honeycomb drusen in young patients with autosomal dominant inheritance.
Marmorstein AD et al. EFEMP1 Doyne Review
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
